KLK3 and prostate cancer: Similar inversions in incidence and mortality of prostate cancer were also documented by previous studies, along with steady declines of willingness in physicians and general population toward PSA screening test after the changes in the USPSTF's recommendations in Canada and Australia (27, 60).